Simulations Plus, Inc. (NASDAQ:SLP) Shares Purchased by Conestoga Capital Advisors LLC

Conestoga Capital Advisors LLC boosted its position in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 15.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,226,262 shares of the technology company's stock after purchasing an additional 290,414 shares during the period. Conestoga Capital Advisors LLC owned approximately 11.08% of Simulations Plus worth $62,090,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Cook Wealth LLC lifted its stake in Simulations Plus by 19.1% during the fourth quarter. Cook Wealth LLC now owns 12,386 shares of the technology company's stock valued at $345,000 after purchasing an additional 1,984 shares during the last quarter. Tributary Capital Management LLC lifted its position in shares of Simulations Plus by 21.7% during the 4th quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company's stock valued at $11,047,000 after acquiring an additional 70,526 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Simulations Plus by 106.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company's stock worth $1,517,000 after acquiring an additional 24,371 shares in the last quarter. Principal Financial Group Inc. grew its holdings in shares of Simulations Plus by 2.6% in the 3rd quarter. Principal Financial Group Inc. now owns 87,273 shares of the technology company's stock worth $2,794,000 after acquiring an additional 2,226 shares during the last quarter. Finally, Franklin Resources Inc. lifted its holdings in shares of Simulations Plus by 7.6% during the third quarter. Franklin Resources Inc. now owns 10,797 shares of the technology company's stock valued at $342,000 after purchasing an additional 766 shares during the last quarter. 78.08% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the transaction, the director now directly owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. The trade was a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 19.40% of the stock is currently owned by insiders.

Simulations Plus Stock Down 1.7 %

Shares of SLP stock traded down $0.61 on Thursday, reaching $35.58. The company's stock had a trading volume of 191,686 shares, compared to its average volume of 296,887. Simulations Plus, Inc. has a 12-month low of $24.00 and a 12-month high of $51.22. The stock's 50 day simple moving average is $30.65 and its 200-day simple moving average is $32.45. The company has a market capitalization of $714.80 million, a P/E ratio of 88.95 and a beta of 0.82.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Stephens began coverage on Simulations Plus in a research report on Friday, November 15th. They issued an "overweight" rating and a $39.00 target price for the company. StockNews.com lowered Simulations Plus from a "hold" rating to a "sell" rating in a research report on Monday, November 4th. William Blair reiterated an "outperform" rating on shares of Simulations Plus in a report on Wednesday, January 8th. BTIG Research decreased their price target on shares of Simulations Plus from $60.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, October 24th. Finally, KeyCorp raised their price objective on Simulations Plus from $35.00 to $37.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $49.40.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.